BERTOPEDICS
ActiveSummary
BERTOPEDICS has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €67,311 and a net result of €15,596. Equity is shrinking by about 2.5% per year across the filed financial years. Its solvency ranks better than 64% of 22,576 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Directors
Directors
1 director, last change in 2023
LAERMANS Bert
CurrentDirector (not named in the articles)
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
3 of this company's 5 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
1 person since 2023, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| LAERMANS Bert |
|
Owners and capital
Capital and shareholders
Capital over the years
- 02-10-2023 Converted to available equity